Mela Sciences (MELA -17%) reverses yesterday's post-session gains and sinks on a disappointing...

|By:, SA News Editor

Mela Sciences (MELA -17%) reverses yesterday's post-session gains and sinks on a disappointing Q4. Higher marketing expenses, coupled with an increase in costs associated with installing its Melafinds systems in medical offices, all conspired to pressure margins.